-+ 0.00%
-+ 0.00%
-+ 0.00%

SOLIGENIX INC - PHASE 3 FLASH2 TRIAL OF HYBRYTE IN CTCL RECOMMENDED TO HALT FOR FUTILITY

Reuters·04/28/2026 11:30:01

Please log in to view news